Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
69 0 » 6 0 (Expand Search)
Showing 321 - 340 results of 102,406 for search '(( 69 0 decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.29s Refine Results
  1. 321
    Tunicamycin produces a concentration- and time-dependent decrease in cell viability in SH-SY5Y cells concomitant with caspase-3 activation.

    Tunicamycin produces a concentration- and time-dependent decrease in cell viability in SH-SY5Y cells concomitant with caspase-3 activation. by Arindam P. Ghosh (317870)

    Published 2013
    “…<p>(A) Treatment of SH-SY5Y cells with tunicamycin (0.1–5µM) for 24 h caused a progressive decrease in cell viability as measured by Calcein AM cleavage assay. …”
    Save to List
    Saved in:
  2. 322
    (R)-albuterol decreases cytokine mRNA levels in activated T cells

    (R)-albuterol decreases cytokine mRNA levels in activated T cells by Marcela A Ferrada (41716)

    Published 2011
    “…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”
    Save to List
    Saved in:
  3. 323
    Cephalometric measurement points.

    Cephalometric measurement points. by Lijuan Liu (136685)

    Published 2025
    Save to List
    Saved in:
  4. 324
    Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study

    Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study by Jilles M. Fermont (3746068)

    Published 2020
    “…In total, 291 of 714 individuals experienced 762 hospitalised AECOPD during five-year follow up. Poorer performance of SPPB was associated with both higher rate (IRR 1.08 per 1 point decrease, 95% CI 1.01 to 1.14) and increased length of stay (IRR 1.18 per 1 point decrease, 95% CI 1.10 to 1.27) for hospitalised AECOPD. …”
    Save to List
    Saved in:
  5. 325
    Flow chart of the study procedures.

    Flow chart of the study procedures. by Kazuhiko Ikeuchi (9234268)

    Published 2023
    “…</p><p>Conclusions</p><p>In a mostly HIV patient population, RPR titer can show more than four-fold spontaneous increase or decrease within 1–3 months. …”
    Save to List
    Saved in:
  6. 326
    Mice carrying 100P mutations show region-specific decreases in proportions of PV-expressing cells.

    Mice carrying 100P mutations show region-specific decreases in proportions of PV-expressing cells. by Malgorzata Borkowska (3166719)

    Published 2016
    “…<p>(<b>A</b>) Significant decreases in the proportions of PV+ cells were observed in fSSp, SSp, vAud and in Vis, but not MPFC. …”
    Save to List
    Saved in:
  7. 327
    Image_1_Decreased Expression of CD69 on T Cells in Tuberculosis Infection Resisters.TIF

    Image_1_Decreased Expression of CD69 on T Cells in Tuberculosis Infection Resisters.TIF by Zhen-Yan Chen (4256125)

    Published 2020
    Save to List
    Saved in:
  8. 328
    Image_2_Decreased Expression of CD69 on T Cells in Tuberculosis Infection Resisters.TIF

    Image_2_Decreased Expression of CD69 on T Cells in Tuberculosis Infection Resisters.TIF by Zhen-Yan Chen (4256125)

    Published 2020
    Save to List
    Saved in:
  9. 329
    Role of Ser77 in ACER3 catalytic site.

    Role of Ser77 in ACER3 catalytic site. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  10. 330
    Linearity of ACER3 activity assay.

    Linearity of ACER3 activity assay. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  11. 331
    Structure of ADPR2 and ACER3.

    Structure of ADPR2 and ACER3. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  12. 332
    The kinetics of ACER3 and mutants.

    The kinetics of ACER3 and mutants. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  13. 333
    Inhibitor assay of ACER3.

    Inhibitor assay of ACER3. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  14. 334
    The sialidase inhibitor Neu5Ac2en decreases growth of wt <i>C. canimorsus 5</i> in presence of macrophages.

    The sialidase inhibitor Neu5Ac2en decreases growth of wt <i>C. canimorsus 5</i> in presence of macrophages. by Manuela Mally (348810)

    Published 2013
    Save to List
    Saved in:
  15. 335
    HPLC chromatogram of standard NBD-C<sub>12</sub>-FA.

    HPLC chromatogram of standard NBD-C<sub>12</sub>-FA. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  16. 336
    Comparison between TLC and HPLC used in this study.

    Comparison between TLC and HPLC used in this study. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  17. 337
    Suggested ACER3 catalytic mechanism.

    Suggested ACER3 catalytic mechanism. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  18. 338
    HPLC chromatogram of ACER3 reaction.

    HPLC chromatogram of ACER3 reaction. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  19. 339
    The effects of neutral and alkaline ceramidase inhibitors on ACER3 activity.

    The effects of neutral and alkaline ceramidase inhibitors on ACER3 activity. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  20. 340
    Increased body weight and decreased expansion of pro-inflammatory CD4+ T-cells from blood in Tg-HD5 rats.

    Increased body weight and decreased expansion of pro-inflammatory CD4+ T-cells from blood in Tg-HD5 rats. by Osiris Marroquin Belaunzaran (224031)

    Published 2015
    Save to List
    Saved in:

Search Tools: